Birmingham, UK – 20th November 2023: Matoke Holdings (Matoke), a privately-owned medical device company developing innovative solutions for chronic wounds to outpace antimicrobial resistance, today announces the appointment of Neil Johnson as Chief Technology Officer.
Neil brings over 15 years of experience within the medical device and over the counter (OTC) healthcare sectors, heading up R&D, Manufacturing, Project Management and Business Transformation teams. He specialises in the design, development and commercialisation of wound care products across global markets.
Guy Reynolds, Chief Executive Officer of Matoke, said: “We are thrilled that Neil is joining the team at Matoke at this exciting junction in our business. He brings considerable expertise that will be crucial as we develop our RO technology across on a number of products in our pipeline.”
Neil Johnson, Chief Technology Officer of Matoke, added: “I’m excited to join Matoke at such a pivotal time, as it seeks to develop its innovative RO technology into class leading antimicrobial wound care products. The growing threat of antimicrobial resistance is significant and there is a large market need for novel antimicrobial wound care products. I look forward to playing a part in bringing these much-needed products to the market and the benefits that these will have on both healthcare workers and patients.”
